Guidelines

Skip to main content

Guidelines

What's new

July 1, 2014

CDC Releases 2014 National Diabetes Statistics Report with New Outlook

The Centers for Disease Control (CDC) has released its... Continue Reading »

May 31, 2014

FDA Issues Strong Safety Warning Against Shasta GenStrip

On April 29, the FDA issued a ... Continue Reading »

April 29, 2014

FDA Advisory Committee Votes Overwhelmingly in Favor of Approving MannKind’s Afrezza for Type 1 and Type 2 Diabetes; FDA Delays Decision

... Continue Reading »

FDA Proposes Updates to Nutrition Facts Labeling for First Time in Two Decades

... Continue Reading »

February 19, 2014

The FDA Announces New, Tighter Home and Healthcare Facility Standards for Blood Glucose Meter Accuracy

... Continue Reading »

January 21, 2014

FDA Removes Restrictions on Avandia, But is it Too Little Too Late?

... Continue Reading »

January 21, 2014

Invokana is Approved in Europe – An Exciting Year for SGLT-2s

On November 22, J&J/Janssen Cilags’ SGLT-2 inhibitor Invokana (canagliflozin) was approved in Europe. This makes... Continue Reading »

January 21, 2014

FDA Approves the SGLT-2 inhibitor Farxiga (dapagliflozin) for Type 2 Diabetes

... Continue Reading »

Pages